Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Simulations Plus, Inc. - Common Stock (NQ:SLP)

25.47 +0.11 (+0.43%)
Streaming Delayed Price Updated: 3:01 PM EDT, Mar 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 108,805
Open 25.37
Bid (Size) 25.44 (2)
Ask (Size) 25.55 (2)
Prev. Close 25.36
Today's Range 25.03 - 25.80
52wk Range 24.00 - 51.22
Shares Outstanding 20,206,550
Dividend Yield 0.94%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Simulations Plus to Present at the KeyBanc Capital Markets Virtual Healthcare Investor Forum
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus to Participate in Upcoming Healthcare Investor Conferences
From Simulations Plus, Inc.
Via Business Wire

Performance

YTD
-8.7%
-8.7%
1 Month
-29.2%
-29.2%
3 Month
-15.2%
-15.2%
6 Month
-20.1%
-20.1%
1 Year
-39.1%
-39.1%

More News

Read More
Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus® Enhancements
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Q1 Earnings Assessment
Via Benzinga
What to Expect from Simulations Plus's Earnings
Via Benzinga
Breaking Down Simulations Plus: 2 Analysts Share Their Views
Via Benzinga
Forecasting The Future: 4 Analyst Projections For Simulations Plus
Via Benzinga
Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Reports First Quarter Fiscal 2025 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Earnings Scheduled For January 7, 2025
Via Benzinga
Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings and Conference Call Date
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus to Participate in the BTIG Digital Health Forum
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus to Participate in the Stephens Annual Investment Conference
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Reports Fourth Quarter and Fiscal 2024 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Optimizes Business Unit Structure to Support Future Growth Following Recent Strategic Acquisitions
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Releases DILIsym® X
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Releases ADMET Predictor® Version 12
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus to Participate in KeyBanc’s 25th Annual Technology Leadership Forum
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Announces New Research Project with the International Collaboration on Cosmetics Safety
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Stock Drops 15% Despite EPS Beat
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence

Frequently Asked Questions

Is Simulations Plus, Inc. - Common Stock publicly traded?
Yes, Simulations Plus, Inc. - Common Stock is publicly traded.
What exchange does Simulations Plus, Inc. - Common Stock trade on?
Simulations Plus, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Simulations Plus, Inc. - Common Stock?
The ticker symbol for Simulations Plus, Inc. - Common Stock is SLP on the Nasdaq Stock Market
What is the current price of Simulations Plus, Inc. - Common Stock?
The current price of Simulations Plus, Inc. - Common Stock is 25.47
When was Simulations Plus, Inc. - Common Stock last traded?
The last trade of Simulations Plus, Inc. - Common Stock was at 03/19/25 03:01 PM ET
What is the market capitalization of Simulations Plus, Inc. - Common Stock?
The market capitalization of Simulations Plus, Inc. - Common Stock is 514.66M
How many shares of Simulations Plus, Inc. - Common Stock are outstanding?
Simulations Plus, Inc. - Common Stock has 515M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.